Masamichi Muramatsu - Genetic Mutations

Author Information

Masamichi Muramatsu is a distinguished researcher affiliated with the Department of Molecular Genetics at the Graduate School of Medical Science, Kanazawa University in Kanazawa, Ishikawa, Japan. His work primarily focuses on the field of genetics, with a significant emphasis on virology and the molecular mechanisms of viral infections.

Research Contributions

Masamichi Muramatsu has made substantial contributions to the study of viral infections, particularly hepatitis and norovirus. His recent research has explored the cross-species transmission of hepatitis E virus, the mechanisms of hepatitis B and D virus entry, and the role of endogenous enzymes in viral hypermutation. Additionally, his work extends to the development of vaccines against hepatitis C virus and the identification of compounds with potential therapeutic effects against SARS-CoV-2. His research is pivotal in understanding viral pathogenesis and developing antiviral strategies.

Aliases

Throughout his academic career, Masamichi Muramatsu has been referenced under various aliases, including M Muramatsu and M. Muramatsu.

Publication and Citation Metrics

Metric	Value
Total Citation Count	17,046
H-Index	50
Total Number of Papers	179

Publications:

Experimental Cross-Species Transmission of Rat Hepatitis E Virus to Rhesus and Cynomolgus Monkeys

DOI: 10.3390/v14020293

Year: 2022

The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro

DOI: 10.1371/journal.ppat.1009983

Year: 2022

Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses

DOI: 10.3390/v14040764

Year: 2022

Evaluation of heat inactivation of human norovirus in freshwater clams using human intestinal enteroids

DOI: 10.1101/2022.01.27.477812

Year: 2022

Activities of endogenous APOBEC3s and uracil-DNA-glycosylase affect the hypermutation frequency of hepatitis B virus cccDNA.

DOI: 10.1099/jgv.0.001732

Year: 2022

Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine.

DOI: 10.1016/j.antiviral.2022.105266

Year: 2022

Hepatitis C Virus-Induced ROS/JNK Signaling Pathway Activates the E3 Ubiquitin Ligase Itch to Promote the Release of HCV Particles via Polyubiquitylation of VPS4A

DOI: 10.1128/jvi.01811-21

Year: 2022

A Cross-Species Transmission of a Camel-Derived Genotype 8 Hepatitis E Virus to Rabbits

DOI: 10.3390/pathogens10111374

Year: 2021

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

DOI: 10.1101/2021.01.31.429001

Year: 2021

The predicted stem-loop structure in the 3′-end of the human norovirus antigenomic sequence is required for its genomic RNA synthesis by its RdRp

DOI: 10.1016/j.jbc.2021.101225

Year: 2021

What Causes Sickle Cell Disease?

What Are the Consequences of Transversions?

What is the Mechanism of Action of TKIs?

What is the Future of Hemophilia Research?

How do Genetic Mutations Affect Health?

How Do Genetic Mutations Affect Immunotherapy?

What is Immunotherapy?

What Are the Symptoms of Hemophilia?

Can Genetic Testing Help?

Should Genetic Mutations Be Patented?

Partnered Content Networks

Relevant Topics